glp 1 effects on inflammation Frontiers Frontiers | The role of

doi: 10.1186/s12967-024-05011-2

At any rate, when administered at equimolar doses to diet-induced obese mice, RG7697 led to a greater weight loss while demonstrating superior insulinotropic and antihyperglycemic effects after a glucose challenge compared to selective GLP-1RAs in db / db mice, lean rats, Zucker diabetic fatty rats, and cynomolgus monkeys [117]

Novo will, however, keep patent protection for semaglutide in Europe and Japan until 2033, and in the US until 2032

The overlapping side effect profiles and distinct mechanisms of action create risks that may be additive or synergistic

Winzeler B, da Conceio I, Refardt J, et al